AnaptysBio
(NASDAQ) ANAB
AnaptysBio Financials at a Glance
Market Cap
$1.75B
Revenue (TTM)
$232.39M
Net Income (TTM)
$26.79M
EPS (TTM)
$-1.08
P/E Ratio
-55.61
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$60.42
Volume
396,310.734
Open
$59.93
Price
$60.42
Volume
396,310.734
Open
$59.93
Previous Close
$60.41
Daily Range
$59.00 - $60.99
52-Week Range
$11.40 - $72.36
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$60.42
Volume
396,310.734
Open
$59.93
Previous Close
$60.41
Daily Range
$59.00 - $60.99
52-Week Range
$11.40 - $72.36
ANAB News
Why AnaptysBio Plummeted Today
ANAB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout AnaptysBio
Industry
Biotechnology
Sector
Health CareEmployees
104
CEO
Daniel R. Faga, MBA
Website
www.anaptysbio.comHeadquarters
San Diego, CA 92121-5801, US
ANAB Financials
Key Financial Metrics (TTM)
Gross Margin
1%
Operating Margin
18%
Net Income Margin
-12%
Return on Equity
-115%
Return on Capital
14%
Return on Assets
-8%
Earnings Yield
-1.80%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.75B
Shares Outstanding
29.10M
Volume
396.31K
Avg. Volume
635.35K
Financials (TTM)
Gross Profit
$232.18M
Operating Income
$47.90M
EBITDA
$50.32M
Operating Cash Flow
$19.70M
Capital Expenditure
$87.00K
Free Cash Flow
$19.61M
Cash & ST Invst.
$311.64M
Total Debt
$14.11M
AnaptysBio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$25.56M
-8.0%
Gross Profit
$24.95M
+286.0%
Gross Margin
97.61%
N/A
Market Cap
$1.75B
N/A
Market Cap/Employee
$12.86M
N/A
Employees
136
N/A
Net Income
$52.88M
-34.5%
EBITDA
$34.03M
-65.0%
Quarterly Fundamentals
Net Cash
$9.10M
-97.2%
Accounts Receivable
$25.75M
+44.0%
Inventory
$0.00
N/A
Long Term Debt
$275.24M
+1921.9%
Short Term Debt
$2.12M
+8.1%
Return on Assets
-8.13%
N/A
Return on Invested Capital
14.17%
N/A
Free Cash Flow
$25.94M
-141.6%
Operating Cash Flow
$25.92M
-142.2%